POAI’s strategic collaborations are helping to build next-generation tools for treating complex diseases and unique services to meet the needs of its patients better. This could drive new revenue growth opportunities. However, the highly competitive oncology drugs market and the company’s faltering financials could make investors anxious.
Here’s what could influence POAI’s performance in the near term:
